{"id":"W2165425991","doi":"10.1016/s0140-6736(12)60079-8","title":"AIDA STEMI: no benefit for intracoronary abciximab","year":2012,"lang":"it","type":"letter","venue":"The Lancet","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Hamilton General Hospital; Université Laval","funders":"Medtronic; AstraZeneca; Eli Lilly and Company","keywords":"Abciximab; Medicine; Cardiology; Myocardial infarction; Percutaneous coronary intervention; Internal medicine; Streptokinase; Thrombolysis; Bivalirudin; Heart failure","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002254256,0.00117139,0.002523165,0.000738018,0.002890897,0.003896923,0.00148307,0.06602603,0.01114913],"category_scores_gemma":[0.02192571,0.0008641288,0.001842514,0.0007876911,0.002833019,0.003049064,0.001252429,0.04692611,0.01107751],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004458862,"about_ca_system_score_gemma":0.003350691,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00414509,"about_ca_topic_score_gemma":0.008455004,"domain_scores_codex":[0.9975742,0.0007288419,0.0002754119,0.0003484357,0.0006193916,0.0004537808],"domain_scores_gemma":[0.9930657,0.004100233,0.0004743781,0.0002238915,0.0007246459,0.001411133],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009982102,0.00009873925,0.001441713,0.0001447587,0.00009012459,0.004400418,0.00008071037,0.00008749523,0.0005003184,0.004058137,0.970882,0.01721744],"study_design_scores_gemma":[0.004250774,0.0007887832,0.005505421,0.001246387,0.000476119,0.008558451,0.0005703123,0.001440744,0.0008440776,0.03814781,0.9379294,0.0002416886],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0007804295,0.002554693,0.0000578025,0.9773212,0.01574413,0.00001153327,0.00009889121,0.0000224831,0.003408735],"genre_scores_gemma":[0.008470379,0.00201645,0.000185828,0.897732,0.08414014,0.00003967059,0.00008945765,0.00002848232,0.0072976],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.06602603,"threshold_uncertainty_score":0.03729761,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06245584845942882,"score_gpt":0.3325745462776054,"score_spread":0.2701186978181765,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}